Gaudium IVF and Women Health Ltd IPO - Check Issue Date, Price, Lot Size & Details with BlinkX.

Gaudium IVF and Women Health Ltd IPO

The company is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years. Gaudium IVF is founded by our Promoter Dr. Manika Khanna, a specialist with advanced training in gynecological endoscopic surgery from Kiel, Germany, and in Gynaec Endoscopy from Melbourne IVF Gujarat Private Limited. The company operates 30+ locations, which comprises of 7 hubs (centers) and 28 spokes (company has entered into a strategic alliance with Spokes i.e Infertility Expert to achieve the mutual goal of spreading awareness about ART and IVF treatment). Its treatments include In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI) and ovulation induction, all its treatment is carefully designed to address a variety of infertility challenges for both male and female.

Gaudium IVF and Women Health Ltd IPO Details

Total Shares Offered

₹ 2,08,86,200

Offer to Public

94,93,700

Retail Max (Shares)

₹ 73,10,170

Pre Issue Promoters Holding

₹ 6,13,85,084

Exchange

BSE

Issue size

₹ 165 Cr

IPO Open Date

Feb 20, 2026

Close Date

Feb 24, 2026

Lot Size

189

Min Investment

₹ 14,175

Issue Type

Book Building

Listing Date

Feb 27, 2026

Gaudium IVF and Women Health Ltd IPO Dates

Feb 20, 2026

Opening date

Feb 24, 2026

Closing date

Feb 25, 2026

Basis of Allotment

Feb 25, 2026

Initiation of Refunds

Feb 26, 2026

Credit of Shares

Feb 27, 2026

Listing date

Details

Sector	Type
Sector	Healthcare
Sub Sector	NA
Issue Type	Book Building

Subscription Status

*Values are in Lakhs

Investor Type	Subscription Times	Shares Offered*	Shares Bid*
QIB	0.65x	10443100	6785478
NII	14.03x	3132930	43960266
Retail	7.55x	7310170	55206522
Employee	0x	0	0
Total	5.07x	20886200	105952266

Investor Type

QIB

NII

Retail

Employee

Total

Subscription Times

0.65x

14.03x

7.55x

5.07x

10443100

3132930

7310170

20886200

6785478

43960266

55206522

105952266

Gaudium IVF and Women Health Ltd Financial Status

Income Statement

Particulars (In Rs. Crores)

Balance Sheet

Particulars (In Rs. Crores)

Particulars (in Rs. Crores)	FY23	FY22	FY21
Revenue from operations	70.72	47.89	44.24
EBITDA	28.72	20.38	20.77
PAT	18.59	9.93	13.26
Total Assets	39.62	28.92	18.16
Share Capital	30.70	0.99	0.99
Total Borrowings	8.74	2.04	1.09
Operating Activities (Net Cash)	20.60	12.06	14.67
Investing Activities (Net Cash)	-1.12	1.25	1.25
Financing Activities (Net Cash)	8.74	2.04	1.09
Net Cashflow	6.73	11.65	14.79

About Gaudium IVF and Women Health Ltd

The Company was originally incorporated in the name of Gaudium IVF and Women Health Private Limited as a private limited company under the Companies Act, 2013, pursuant to a certificate of incorporation dated March 24, 2015 issued by the RoC, Delhi and Haryana. Subsequently, the Company was converted from a private limited company into a public limited company pursuant to a special resolution passed in the extraordinary general meeting of its Shareholders held on September 28, 2024 and consequently, the name of our Company was changed to `Gaudium IVF and Women Health Limited', and a fresh certificate of incorporation dated October 24, 2024 was issued by the Central processing center.

According to Infomerics Research Report, the global IVF market, valued at USD 27.49 billion in 2024, is projected to double to USD 54.60 billion by 2034 at a CAGR of 7.10%. India's IVF market is set to grow faster, from USD 1.32 billion to USD 4.54 billion over the same period, at a CAGR of 13.13%, expanding its global share from 4.8% to 8.3%. Growth is driven by rising infertility, delayed marriages, lifestyle shifts, and increasing maternal age. Technological advances, regulatory support, and improving access further strengthen adoption. Declining global fertility underscores rising reliance on IVF, positioning India as a key growth hub.

Gaudium IVF and Women Health Ltd Key Points

Strengths

Clinical excellence and advanced medical technologies to deliver quality healthcare.

Ability to attract, train and retain high-quality doctors and staff.

Scalable model and disciplined approach for growth.

Stable and robust financial performance.

Professional management and experienced leadership of our Promoters i.e., Manika Khanna and Peeyush Khanna.

Risk

The Company is in engaged in the business of providing healthcare services mainly rendering various fertility treatments such as In Vitro Fertilization (IVF), intrauterine insemination (IUI), intracytoplasmic sperm injection (ICSI), Egg Freezing, laser assisted embryo implantation amongst others and is subject to various operational, reputational, medical and legal risks associated with the operations of healthcare services. An inability to provide quality healthcare catering to the needs of the customers could adversely affect the reputation, business prospects and financial performance of the Company.

The Company may highly dependent on doctors, nurses and other healthcare professionals and the business will be impacted significantly if the Company is unable to attract / retain such professionals.

The business of the Company depends on the strength of the brand and reputation of the Company. Failure to maintain and enhance the brand and reputation, and any negative publicity and allegations in the media against the Company, even if untrue, may adversely affect the brand, reputation and trust in, services of the Company, which could result in a material adverse impact on business, financial condition, results of operations and prospects of the Company.

Strategy

Establishment of New IVF Centers.

How To Apply for Gaudium IVF and Women Health Ltd IPO Online?

Step 1:

Step 2:

From the list of open IPOs, select the IPO you want to invest.

Step 3:

Go through the IPO details like lot size, price band, about the company, etc.

Step 4:

Click ‘Apply IPO’ to apply and enter the number of lots and bidding price along with your UPI ID.

Step 5:

Confirm your bid and accept the payment mandate sent to your UPI App for completing the IPO application.

FAQs on IPO (Initial Public Offering)

What is the issue size of the Gaudium IVF and Women Health Ltd IPO?

Gaudium IVF and Women Health Ltd's IPO offers shares for up to 90 It begins on Feb 20, 2026 and ends on Feb 24, 2026.

What is the price of the Gaudium IVF and Women Health Ltd IPO?

The price of Gaudium IVF and Women Health Ltd IPO ranges between ₹75 to ₹79 per share.

What are the open and close dates for the Gaudium IVF and Women Health Ltd IPO?

The Gaudium IVF and Women Health Ltd IPO opens on Feb 20, 2026 and closes on Feb 24, 2026.

When will the Gaudium IVF and Women Health Ltd IPO be allotted?

The allotment for the Gaudium IVF and Women Health Ltd IPO will be finalised on Feb 25, 2026. The shares will be listed on BSE and NSE on Feb 27, 2026.

What is the minimum lot size required for Gaudium IVF and Women Health Ltd IPO?

The minimum lot size for Gaudium IVF and Women Health Ltd IPO is 189 shares, priced between ₹75 to ₹79 per share.

What is the GMP of Gaudium IVF and Women Health Ltd IPO?

The GMP (Grey Market Premium) of Gaudium IVF and Women Health Ltd IPO fluctuates based on market demand and sentiment.

How do you check the allotment status of Gaudium IVF and Women Health Ltd IPO?

To check the allotment status of Gaudium IVF and Women Health Ltd IPO, visit the registrar's website, select the IPO, enter your PAN Card number, Application Number, or DP Client ID, and click 'search.'

Where is the Gaudium IVF and Women Health Ltd IPO getting listed?

The Gaudium IVF and Women Health Ltd IPO is getting listed on the BSE and NSE. Bidding opens on Feb 20, 2026, and closes on Feb 24, 2026. The allotment is finalised on Feb 25, 2026.

How do you apply for the Gaudium IVF and Women Health Ltd IPO?

To apply for the Gaudium IVF and Women Health Ltd IPO, download the BlinkX app, complete KYC, select the IPO, enter bid details, and submit. Verify UPI payment for shares allotment.